Beyond the Limits: Clinical Utility of Novel Cardiac Biomarkers

Table 4

Summary of original articles from the literature proving the significance of MR-PAMP as cardiac biomarker.

Authors	Year	Study type	Number of patients	Statistical significance
Eggers et al. [57]	2013	Cohort study	1797 patients over 70 years of age
Smith et al. [58]	2010	Cohort study	5187 individuals	Heart failure, ; atrial fibrillation,
Von Haehling et al. [59]	2007	Clinical study	525 patients with chronic heart failure
Von Haehling et al. [60]	2010	Clinical study	501 patients with chronic heart failure